Markets

Insider Trading

Hedge Funds

Retirement

Opinion

20 Cities with the Highest Opioid Deaths in the U.S.

In this piece, we will take a look at 20 cities with the highest opioid deaths in the U.S. For more cities, head on over to 5 Cities with the Highest Opioid Deaths in the U.S.

America is one of the most unique countries in the world. The American economy is the largest in the world and the country is the richest nation in human history. America’s defense spending is higher than the next several countries put together, and the U.S. military the capability to project power in any region in the world. American industry has pioneered disruptive technologies such as the Internet and the semiconductor – both of which have shaped the world as it is today.

However, at the same time, some problems are uniquely American as well. For instance, America has the highest rate of gun violence in the world. And, the American healthcare system is known for its high costs. At the same time, one of the worst prescription drug crises in modern history also originated in the U.S. This is the renowned opioid crisis, which saw doctors prescribe highly potent painkillers to patients only to see them become addicted to the medicine instead. In fact, while opioid misuse is quite well known in America, a little known fact is that Americans consume 80% of the world’s opioids even though America represents roughly 5% of the world’s population.

The opioid crisis also led to one of the largest court settlements in American history (another unique fact about the U.S. is a tough legal system). This settlement was made by the consulting firm McKinsey after it was discovered that it had advised drug makers to turbocharge their sales of addictive drugs to the market. Analysis of court documents filed against McKinsey showed the consulting firm’s work with the OxyContin maker Purdue Pharma to incentivize retailers to stock up on more pills. After Purdue found out that Walgreens had reduced its prescription pill inventory, McKinsey reportedly advised Purdue to lobby the pharmacy chain to stock more products. At the same time, McKinsey also developed a multi pronged strategy to boost OxyContin sales. This included lobbying doctors who were already prolific prescribers of OxyContin to push out even more pills, and if they refused, then build up the pressure through patients to force the doctors to comply. Additionally, and as if this weren’t enough, McKinsey also advised its client to offer distributors a rebate for every overdose on a pill they sold. This naturally not only encouraged the distributors to supply more pills but also countered a potential ethical dilemma with a financial incentive.

The end result led to McKinsey agreeing to pay nearly $600 million to 47 American states to redress the harms that had resulted from its devastating strategies. This massive figure indicates the scale of the opioid crisis. Just as 80% of the world’s opioids are used in the U.S., most of the drug deaths in America are also due to these deadly pills. Data from the Centers for Disease Control and Prevention (CDC) shows that there were 91,799 drug related deaths in America in 2020 – out of which 70% are related to opioids. This also opens up a massive market to treat opioid abuse disorders. According to research from Future Market Insights, this market will be worth $3 billion by the end of this year. From then until 2030 the market is expected to grow at a compounded annual growth rate (CAGR) of 10.5% to be worth $8.4 billion by the end of 2033. This growth rate makes the market one of the few that will see an accelerated growth rate in the future, as the research firm shares that between 2018 and 2022 the industry had growth by 7.89%.

Currently, there are three medications that help people wean away from their opioid addiction. These are Methadone, Buprenorphine, and Naltrexone. Out of these, Buprenorphine received renewed attention recently after the FDA approved Brixadi, an injectable form of the drug. Another drug called Opvee is a nasal spray designed to combat opioid overdoses.

Another firm that recently agreed to a settlement related to opioids is Teva Pharmaceutical Industries Limited (NYSE:TEVA) and management shared details about it in a recent earnings call where it outlined:

I also want to provide you with an update on the progress with the nationwide opioid litigation settlement.

During the previous quarter, we had confirmed a high level of state participation, 49 out of 50 states. Based on a strong state participation, we decided to move ahead to the next phase with the subdivision participation, which I’m happy to report is also going very well. To date, we have confirmed participation from over 99% of the litigating subdivision from those participating states. Overall, with the level of broad support we have seen by the states and subdivisions, we expect to move forward firmly in the process, and we anticipate making the first settlement payment in the second half of 2023. Now moving to Slide 20 for a review of our non-GAAP performance. I’ve already discussed our first quarter revenue, which totaled approximately $3.7 billion and represented a growth of 4% in local currency terms compared to the first quarter of 2022.

With these details in mind, let’s take a look at the U.S. cities with the greatest opioid deaths.

Our Methodology

To compile our list of American cities with the highest number of opioid deaths, we used data from Drexel University’s Big City Health Coalition to choose American cities, large and small, rich and poor, with the largest rate of opioid-related deaths per 100,000 people. The data is irrespective of race or gender, and it is compiled using the CDC’s data.

 Cities with the Highest Opioid Deaths in the U.S.

20. New York City, New York

Opioid-related drug overdose deaths (per 100,000 population, age-adjusted): 16

New York City is America’s largest city in terms of population with 8.8 million people. Despite this, it ranks on the bottom of our list of the twenty American cities with the highest number of opioid overdose deaths.

19. Portland, Oregon

Opioid-related drug overdose deaths (per 100,000 population, age-adjusted): 16.6

Portland is the largest city in Oregon and has more than six hundred thousand residents. It is an important port city, which handles millions of tons of cargo each year.

18. Seattle, Washington

Opioid-related drug overdose deaths (per 100,000 population, age-adjusted): 16.9

Seattle is a major city in the American Northeast. It has rapidly emerged as a technology hub in its state and is known for having the headquarters of Amazon.

17. Denver, Colorado

Opioid-related drug overdose deaths (per 100,000 population, age-adjusted): 21

Denver is the capital of Colorado and houses more than seven hundred thousand people. Its location makes it a transportation hub in its state.

16. Phoenix, Arizona

Opioid-related drug overdose deaths (per 100,000 population, age-adjusted): 26.9

Phoenix is one of the largest cities in America through its population of more than 1.6 million people. It is also an economic hub and has headquarters of several Fortune 500 companies.

15. Minneapolis, Minnesota

Opioid-related drug overdose deaths (per 100,000 population, age-adjusted): 27

Minneapolis is one of the smaller cities on our list despite being Minnesota’s largest city. It has a variety of important banking and retail companies.

14. Boston, Massachusetts

Opioid-related drug overdose deaths (per 100,000 population, age-adjusted): 29.5

Boston is one of the most prosperous and developed cities in America. It is a hub for the biotechnology industry and also has some of the largest and best hospitals in America.

13. Chicago, Illinois

Opioid-related drug overdose deaths (per 100,000 population, age-adjusted): 32.6

Chicago is the third largest city in America in terms of population through its 2.7 million residents. It is also one of America’s major business cities, but one that often suffers from high crime rates.

12. Tucson, Arizona

Opioid-related drug overdose deaths (per 100,000 population, age-adjusted): 35.9

Tucson houses more than half a million people, making it one of Arizona’s largest cities. It is also one of the oldest cities in America since it was set up in the late eighteenth century.

11. San Francisco, California

Opioid-related drug overdose deaths (per 100,000 population, age-adjusted): 36.04

San Francisco is the technology hub in America, with most of the world’s biggest technology firms either located in the city or near it.

10. Memphis, Tennessee

Opioid-related drug overdose deaths (per 100,000 population, age-adjusted): 37.8

Memphis is the second largest city in Tennessee in terms of population, however, it ranks the highest in the state when it comes to the unfortunate statistic of high opioid abuse deaths.

9. Washington, D.C.

Opioid-related drug overdose deaths (per 100,000 population, age-adjusted): 38.6

Washington, D.C. is the capital city of America. It has some of the highest costs of living in the U.S.

8. Indianapolis, Indiana

Opioid-related drug overdose deaths (per 100,000 population, age-adjusted): 44.8

Indianapolis is the capital of Indiana and houses close to a million people. It is also a logistics and transportation hub in its state.

7. Milwaukee, Wisconsin

Opioid-related drug overdose deaths (per 100,000 population, age-adjusted): 47

Milwaukee is the largest city in Wisconsin and has a diversified economy with several Fortune 500 firms.

6. Detroit, Michigan

Opioid-related drug overdose deaths (per 100,000 population, age-adjusted): 48.7

Detroit is the largest city in Michigan and an important player in the automotive industry.

Click to continue reading and see the 5 Cities with the Highest Opioid Deaths in the U.S.

Suggested Articles:

Disclosure: None. 20 Cities with the Highest Opioid Deaths in the U.S. is posted on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…